1. Home
  2. ADAG vs JACK Comparison

ADAG vs JACK Comparison

Compare ADAG & JACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$4.47

Market Cap

260.3M

Sector

Health Care

ML Signal

HOLD

Logo Jack In The Box Inc.

JACK

Jack In The Box Inc.

HOLD

Current Price

$17.01

Market Cap

258.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADAG
JACK
Founded
2011
1951
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
260.3M
258.3M
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
ADAG
JACK
Price
$4.47
$17.01
Analyst Decision
Strong Buy
Hold
Analyst Count
4
14
Target Price
$8.25
$21.00
AVG Volume (30 Days)
270.7K
1.1M
Earning Date
04-01-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.40
Revenue
N/A
$1,465,314,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.04
P/E Ratio
N/A
$43.00
Revenue Growth
N/A
N/A
52 Week Low
$1.44
$8.92
52 Week High
$4.85
$25.34

Technical Indicators

Market Signals
Indicator
ADAG
JACK
Relative Strength Index (RSI) 62.38 67.47
Support Level $3.21 $10.70
Resistance Level $4.66 $17.86
Average True Range (ATR) 0.45 1.53
MACD 0.09 0.55
Stochastic Oscillator 75.46 89.27

Price Performance

Historical Comparison
ADAG
JACK

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

About JACK Jack In The Box Inc.

Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America. Its core business includes the Jack in the Box hamburger chain, known for a broad menu that features hamburgers, tacos, sandwiches, salads, and breakfast items. The company also operates the Del Taco brand, which offers a variety of both Mexican and American favorites such as burritos and fries. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.

Share on Social Networks: